Module 1 of 5

The IDE framework

What Part 812 covers, what is exempt, and the basic rules for investigational devices.

Lecture for Module 1. Open the playlist on YouTube

Key points

  • Part 812 applies to clinical investigations of devices to determine safety and effectiveness (812.2(a)).
  • A device found substantially equivalent to a pre-May 28, 1976 device, and used per the labeling FDA reviewed, is exempt, except 812.119 (812.2(c)(2)).
  • Certain noninvasive diagnostic device studies are exempt when diagnosis is confirmed by an established method (812.2(c)(3)).
  • An investigational device carries the "investigational use" caution statement (812.5(a)).
  • Promoting or test marketing an investigational device is prohibited (812.7).
  • IRBs reviewing device studies comply with Part 56; consent follows Part 50 (812.60, 812.100).

Reading for this module

Module 1 quiz

10 questions. Pass mark: 9 of 10. Questions and answers are shuffled each time, and you see the explanations when you finish.